Bodal Chemicals (BODALCHEM)₹161.27+0.68%Dyes And Pigments
In the Jun 2026 quarter (consolidated), Bodal Chemicals reported sales of ₹707 Cr, up 56.1% from Jun 2025, and net profit of ₹29.99 Cr, up 200.2% year on year. For the year to Mar 2026, sales were ₹2,008 Cr and net profit ₹47.96 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 329 | 338 | 393 | 421 | 428 | 442 | 450 | 453 | 479 | 489 | 587 | 707 |
| Expenses | 306 | 314 | 367 | 387 | 395 | 398 | 403 | 406 | 456 | 467 | 518 | 639 |
| Operating Profit | 23.06 | 24.06 | 25.07 | 34.12 | 33.12 | 44.14 | 47.18 | 48.14 | 23.08 | 22.08 | 69.16 | 69.19 |
| OPM % | 7.0% | 7.0% | 6.0% | 8.0% | 8.0% | 10.0% | 10.0% | 10.0% | 4.8% | 4.5% | 12.0% | 10.0% |
| Other Income | 6.01 | 5.01 | 5.01 | 2.01 | 5.01 | 1.01 | 2.01 | 4.01 | 20.04 | 15.02 | 3.01 | 6.01 |
| Interest | 13.02 | 12.02 | 16.01 | 21.02 | 20.03 | 20.04 | 21.02 | 22.02 | 20.02 | 19.02 | 18.03 | 19.04 |
| Depreciation | 13.94 | 14.95 | 16.95 | 16.95 | 16.95 | 16.94 | 16.95 | 17.93 | 16.95 | 16.95 | 16.93 | 16.94 |
| Profit before tax | 2.01 | 2.01 | −1.99 | −1.01 | 0.99 | 8.01 | 12.01 | 12.99 | 5.99 | 0.00 | 35.99 | 39.01 |
| Tax % | 25.9% | 48.9% | −200.1% | −19.1% | 123.9% | 33.9% | −25.1% | 24.0% | −8.1% | 0.0% | 10.9% | 21.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.99 | 0.99 | 1.99 | −0.99 | 0.00 | 4.99 | 13.99 | 9.99 | 5.99 | 0.00 | 31.97 | 29.99 |
| EPS (Rs) | 0.09 | 0.07 | 0.15 | −0.08 | −0.01 | 0.42 | 1.14 | 0.75 | 0.47 | 0.01 | 2.54 | 2.40 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 905 | 1,230 | 1,140 | 1,420 | 1,372 | 1,223 | 2,049 | 1,570 | 1,392 | 1,741 | 2,008 | 2,262 |
| Expenses | 757 | 1,005 | 944 | 1,184 | 1,234 | 1,137 | 1,832 | 1,438 | 1,282 | 1,574 | 1,846 | 2,080 |
| Operating Profit | 150 | 227 | 197 | 237 | 138 | 87.26 | 221 | 133 | 111 | 168 | 161 | 184 |
| OPM % | 16.0% | 18.0% | 17.0% | 17.0% | 10.0% | 7.0% | 11.0% | 8.0% | 8.0% | 10.0% | 8.0% | 8.1% |
| Other Income | 19.02 | 15.03 | 8.01 | 13.02 | 10.01 | 16.04 | −2.01 | 12.02 | 9.01 | 2.01 | 42.06 | 44.08 |
| Interest | 12.02 | 9.01 | 5.01 | 9.02 | 19.03 | 17.03 | 29.07 | 41.06 | 54.04 | 82.08 | 79.12 | 76.11 |
| Depreciation | 25.89 | 28.89 | 11.95 | 20.92 | 27.89 | 29.89 | 46.85 | 52.84 | 59.81 | 68.78 | 69.71 | 67.77 |
| Profit before tax | 131 | 204 | 186 | 219 | 101 | 55.01 | 142 | 50.97 | 4.99 | 19.02 | 53.98 | 80.99 |
| Tax % | 34.0% | 34.9% | 32.9% | 35.0% | 14.9% | 27.9% | 30.9% | 25.0% | −37.1% | 4.0% | 11.9% | — |
| Exceptional items | 5.02 | 3.01 | 1.01 | 2.01 | 0.00 | 0.00 | −12.04 | 1.01 | −6.02 | −9.03 | 0.00 | 0.00 |
| Net Profit | 85.99 | 133 | 122 | 141 | 85.99 | 39.99 | 98.91 | 37.99 | 5.99 | 17.99 | 47.96 | 67.95 |
| EPS (Rs) | 7.86 | 12.14 | 10.00 | 11.69 | 7.11 | 3.42 | 8.49 | 3.02 | 0.50 | 1.46 | 3.79 | 5.42 |
| Dividend payout % | 7.9% | 7.0% | 8.0% | 6.9% | 10.9% | 22.9% | 8.9% | 3.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21.99 | 22.02 | 21.99 | 23.99 | 23.99 | 24.01 | 24.01 | 24.02 | 24.99 | 25.04 | 25.01 | 25.00 |
| Reserves | 135 | 213 | 341 | 673 | 805 | 906 | 951 | 1,028 | 1,052 | 1,057 | 1,081 | 1,132 |
| Borrowings | 233 | 143 | 151 | 180 | 170 | 256 | 452 | 674 | 758 | 903 | 910 | 811 |
| Other Liabilities | 144 | 132 | 193 | 194 | 290 | 268 | 313 | 385 | 284 | 295 | 326 | 387 |
| Total Liabilities | 534 | 510 | 706 | 1,072 | 1,290 | 1,455 | 1,740 | 2,111 | 2,119 | 2,282 | 2,340 | 2,356 |
| Fixed Assets | 191 | 192 | 222 | 438 | 611 | 658 | 799 | 819 | 968 | 1,316 | 1,304 | 1,242 |
| CWIP | 2.99 | 0.00 | 8.99 | 18.98 | 25.98 | 6.99 | 13.97 | 69.97 | 193 | 67.97 | 60.97 | 66.94 |
| Investments | 2.01 | 2.01 | 17.05 | 17.06 | 6.02 | 3.01 | 6.02 | 0.00 | 0.00 | 13.05 | 0.00 | 0.00 |
| Other Assets | 338 | 315 | 458 | 598 | 648 | 787 | 921 | 1,224 | 958 | 885 | 975 | 1,047 |
| Inventories | 78.27 | 90.36 | 131 | 113 | 209 | 220 | 308 | 447 | 294 | 268 | 338 | 325 |
| Trade receivables | 197 | 167 | 188 | 284 | 330 | 454 | 468 | 590 | 420 | 381 | 399 | 439 |
| Cash & equivalents | 2.99 | 3.99 | 16.98 | 5.99 | 9.99 | 19.99 | 15.98 | 14.99 | 18.99 | 32.99 | 35.98 | 20.98 |
| Total Assets | 534 | 510 | 706 | 1,072 | 1,290 | 1,455 | 1,740 | 2,111 | 2,119 | 2,282 | 2,340 | 2,356 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 198 | 131 | 104 | 6.99 | 186 | 9.98 | −12.98 | −13.98 | 290 | 204 | 114 | 176 |
| Cash from investing activity | −35.02 | −23.03 | −67.01 | −256 | −128 | −79.09 | −168 | −170 | −315 | −278 | −41.02 | 11.01 |
| Cash from financing activity | −162 | −109 | −22.94 | 236 | −50.92 | 75.82 | 178 | 181 | 32.95 | 80.87 | −72.88 | −191 |
| Net cash flow | 0.00 | −0.99 | 13.99 | −12.99 | 7.01 | 7.01 | −3.01 | −2.99 | 7.99 | 6.99 | 0.00 | −4.99 |
| Capex | 35.50 | 24.40 | 58.83 | 229 | 148 | 52.14 | 178 | 159 | 338 | 245 | 46.44 | 35.76 |
| Free cash flow | 162 | 107 | 45.08 | −221 | 38.10 | −43.11 | −191 | −170 | −29.04 | −29.06 | 69.18 | 180 |
| CFO / OP % | 129.0% | 111.0% | 76.0% | 34.0% | 105.9% | 19.9% | −4.0% | 11.0% | 222.9% | 181.9% | 65.0% | 109.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 70 | 68 | 57 | 92 | 86 | 122 | 140 | 106 | 98 | 101 | 84 | 81 |
| Inventory days | 44 | 58 | 61 | 60 | 87 | 92 | 142 | 142 | 120 | 140 | 140 | 107 |
| Days payable | 61 | 66 | 72 | 78 | 90 | 86 | 101 | 80 | 71 | 101 | 96 | 80 |
| Cash conversion cycle | 50 | 58 | 43 | 71 | 79 | 124 | 178 | 165 | 144 | 137 | 125 | 105 |
| Working capital days | 23 | 18 | 21 | 58 | 50 | 65 | 73 | 55 | 49 | 19 | 20 | 27 |
| ROCE % | 38.9% | 35.0% | 46.0% | 26.9% | 24.0% | 10.9% | 5.0% | 12.0% | 5.0% | 3.0% | 6.0% | 7.0% |
For the Jun 2026 quarter, Bodal Chemicals reported sales of ₹707 Cr, up 56.1% year on year and net profit of ₹29.99 Cr, up 200.2% year on year. The operating margin was 10.0%.
Bodal Chemicals' sales for the year to Mar 2026 were ₹2,008 Cr; over the last twelve months they were ₹2,262 Cr.
Net profit for the year to Mar 2026 was ₹47.96 Cr, and ₹67.95 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.42.
Bodal Chemicals reported borrowings of ₹811 Cr at Mar 2026, against cash and equivalents of ₹20.98 Cr.
Cash from operations was ₹176 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹180 Cr.